NEOG vs BCAL

For growth investors, Southern California Bancorp (BCAL) is the stronger pick with 26.

2% revenue growth year-over-year, versus -3. 2% for Neogen Corporation (NEOG). Southern California Bancorp (BCAL) offers the better valuation at 9. 9x trailing P/E (11. 4x forward), making it the more compelling value choice. Analysts rate Southern California Bancorp (BCAL) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Southern California Bancorp is actually cheaper at 11.

4x.

Over the past 5 years, Southern California Bancorp (BCAL) delivered a total return of +44.

0%, compared to -80. 6% for Neogen Corporation (NEOG). Over 10 years, the gap is even starker: BCAL returned +133. 3% versus NEOG's -49. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Southern California Bancorp (BCAL) is the lower-risk stock at 0.

90β versus Neogen Corporation's 1. 83β — meaning NEOG is approximately 104% more volatile than BCAL relative to the S&P 500. On balance sheet safety, Southern California Bancorp (BCAL) carries a lower debt/equity ratio of 12% versus 44% for Neogen Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Southern California Bancorp (BCAL) is pulling ahead at 26.

2% versus -3. 2% for Neogen Corporation (NEOG). On earnings-per-share growth, the picture is similar: Southern California Bancorp grew EPS 777. 3% year-over-year, compared to -114. 6% for Neogen Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Southern California Bancorp (BCAL) is the more profitable company, earning 27.

1% net margin versus -122. 1% for Neogen Corporation — meaning it keeps 27. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BCAL leads at 37. 8% versus 1. 1% for NEOG. At the gross margin level — before operating expenses — BCAL leads at 79. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Southern California Bancorp (BCAL) trades at 11.

4x forward P/E versus 25. 7x for Neogen Corporation — 14. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NEOG: 19. 8% to $11. 00.

In this comparison, BCAL (0.

5% yield) pays a dividend. NEOG does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Southern California Bancorp (BCAL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

90), 0. 5% yield, +133. 3% 10Y return). Neogen Corporation (NEOG) carries a higher beta of 1. 83 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BCAL: +133. 3%, NEOG: -49. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (NEOG (Healthcare) and BCAL (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: NEOG is a small-cap quality compounder stock; BCAL is a small-cap high-growth stock. BCAL pays a dividend while NEOG does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.